BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Hippocampus, Laryngoscope, Trichostatin A, rs4950928, FXYD4, T cell differentiation)
Bookmark Forward

QuickView for GH receptor (gene)


Body Atlas

Most Correlated Tissues

  1. Omental adipose tissue
  2. Liver
  3. Adipose tissue subcutaneous
  4. Adipose tissue
  5. Synovial membrane
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. True dwarfism
  2. Alpha-1-antitrypsin deficiency
  3. Gastrointestinal hemorrhage
  4. Immunoglobulin G4 deficiency
  5. Disorder of digestive system
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. pegvisomant
  2. Human Growth Hormone
  3. 1-(5-(2-thenyloxy)-1H-indol-3-yl)propan-2-amine
  4. Dichlorvos
  5. Alprenolol
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. ZNF788
  2. TMPRSS2
  3. MYT1
  4. GHRH
  5. CDKN1B
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. GHR signalling: Receptor activation and degradation mechanisms.
  2. GH receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: prel…
  3. Fasting and prolonged food restriction differentially affect GH secretion independently of GH recept…
  4. Hypothalamic GHR-SIRT1 Axis in Fasting.
  5. Classical and novel GH receptor signaling pathways.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Evaluation of Somatostatin Receptors and GH Receptor Expression on Bone of Acromegalic Patients (ACR…
  2. Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either W…
  3. Effects of GH and Lirglutide on AgRP
  4. Effect of Pegvisomant on GH/IGF-I Relationship in GHD
  5. Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.